Photo of Alejandro Berenstein

Alejandro Berenstein

Print ProfilePrint Profile


  • American Board of Radiology


  • MD, Univ. Nacional Autonoma De Mexico

  • Internship, Transitional
    Mount Sinai Hospital

  • Residency, Radiology (Diag)
    Mount Sinai Hospital

  • Fellowship, Neuroradiology
    New York University Medical Center


    Alejandro Berenstein, MD is the Director of the Hyman-Newman Institute for Neurology and Neurosurgery at Roosevelt Hospital in New York City and the Director of the Pediatric Cerebrovascular Surgery Program. He is a pioneer in the new field in medicine “Endovascular Surgery” and established the first comprehensive center for the multidisciplinary treatment of head, neck and peripheral vascular lesions. His contributions extend from the description of the functional vascular anatomy, understanding and describing the diseases, to the development of multiple medical devises to treat them used throughout the world.

    Dr. Berenstein has authored over 150 publications in peer-reviewed journals, more than 25 chapters in the field, and 9 books including the five volumes groundbreaking textbook, “Surgical Neuroangiography.” Among the more than 30 awards, in 1989 he received the Ramon y Cajal Award in Medicine for distinguished Latin American Physicians. In 1998 The First Cerebrovascular Luessenhop Award from the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS); Section of Cerebrovascular Surgery. In 2001 awarded the Paolo Raimondi Award from the AANS/CNS on Pediatric Neurological Surgery, and is the only physician to received both. In 2007 he received the Physician of the Year from Vascular Birthmark Foundation, for his work with children with vascular birth defects. In 2007 the Boston Scientific Neurovascular Lifetime Achievement Award for excellence in research and clinical applications. In 2008 the Heart of New York Stroke Spotlight Award from the American Heart and Stroke Association. Honorary Member of the Japanese Society of Neuroendovascular Therapy, in 2009 he received the first Serbinenko Golden Sign Award in Neurosurgery in Moscow. He has been visiting professor, lecturer and faculty in over 600 occasions. He became the first president of the World Federation of Interventional and Therapeutic Neuroradiology and third president of the American Society of Interventional and Therapeutic Neuroradiology; and has been the President of SILAN the Latin-American Society of Neuroradiology for 2012-2013.


  • 2012 -
    Pioneering Award
    Society of Vascular and Interventional Neuroradiology

  • 2012 -
    15th Annual Gala
    St. Luke Roosevelt Hospital

  • 2010 -
    Merit of Achievement Award
    Eve Fenton Love-All Foundation Inc.

  • 2010 -
    World Federation of Interventional and Therapeutic Neuroradiology Founding Members Award

  • 2009 -
    Serbinenko Golden Sign Award

  • 2008 -
    New York Stroke Spotlight Award
    American Heart and American Stroke Association

  • 2008 -
    Honorary Member
    Japanese Society of Neuroendovascular Therapy

  • 2007 -
    Man of the Year Award
    Needlers Foundation

  • 2007 -
    Physician of the Year Award
    Vascular Birthmark Foundation

  • 2007 -
    Boston Scientific Neurovascular Lifetime Achievement Award

  • 2005 -
    El Comite Organizador del XVII Congresso de la Sociedad IberolatinoAmeriana de Neuroradiologia
    Diagnostica y Terapeutica Rinde Homenaje al Socio Fundador de Silan

  • 2001 -
    Paolo Raimondi Lecturer Award
    American Association of Neurological Surgeons (AANS)

  • 1998 -
    The First Luessenhop Award
    American Association of Neurological Surgeons (AANS)

  • 1997 -
    Distinguished Physicians Award
    Needlers Foundation

  • 1993 -
    Distinguished Service Award
    World Federation of Interventional and Therapeutic Neuroradiology (WFITN)

  • 1992 -
    Gratitude and Appreciation Award
    The Radiological Society of North America

  • 1989 -
    Ramon y Cajal Award in Medicine for Distinguished Latin American Physicians

  • 1979 -
    Magna Cum Laude
    17th Annual Scientific Meeting (ASNR)

  • 1966 -
    Second Place for High Notes
    Universidad Nacional Autonoma de Mexico (UNAM)

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Berenstein did not report having any of the following types of financial relationships with industry during 2013 and/or 2014: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central


Klingenstein Clinical Center Floor 1-North
1450 Madison Avenue
New York, NY 10029

Tel: 212-241-3400
Fax: 646-537-2299
The Mount Sinai Hospital

Klingenstein Clinical Center, 1-North
1450 Madison Avenue
New York, NY 10029

Tel: 212-241-3400
Fax: 646-537-2299
Get Directions

Office Hours:
  • Monday 9:00am - 5:00pm
  • Tuesday 9:00am - 5:00pm
  • Wednesday 9:00am - 5:00pm
  • Thursday 9:00am - 5:00pm
  • Friday 9:00am - 5:00pm
  • Spanish
Payment Methods
  • Master Card
  • Visa
  • American Express
  • Personal Check
  • Cash
  • Other
  • Credit Card (Other)